A launch team needs the competitive map before it can plan. An access team needs the payer logic before it can build the case. Neither has six weeks to wait for it. AXLRx is a custom-built commercial consulting engine that delivers evidence-led answers to the questions that move your decision — competitive, patient and payer intelligence, scoped to your asset, in 72 hours. A syndicated report describes the market. An AXLRx brief frames the decision your launch and access teams have to make.
It is a service, not a subscription. There is no platform to operate, no seat licence and no dashboard to learn. You bring the question in front of you, and we return a PDF brief, an Excel model and a PowerPoint readout. Every figure is verified against a live source. If it cannot be sourced, it does not ship.
Three disciplines, one standard: verify or drop.
Live connectors to the primary record: regulatory, clinical, epidemiological, financial and payer sources. No secondary summaries.
Every claim is cited to a live PMID, trial ID or URL at the point of writing, numerically cross-checked, then re-checked in an independent audit pass. Model memory is never a source.
A decision-structured PDF, an editable Excel model and a PowerPoint readout. Every brief includes an analyst review and a 45-minute call.
Built by pharma strategy veterans, not generalist AI engineers. Every brief is reviewed by an experienced commercial consultant before it reaches you.
Pharma commercial operations across GCC, South Asia and Europe — field sales, business development, field force strategy, analytics and commercial program leadership. Specialisation in rare disease, specialty and market access.
Commercial analysts who author and review every brief against the verify-or-drop standard.
Clinical and ex-payer advisors who pressure-test the commercial read for each therapy area before delivery.
Scope confirmed in 24 hours. Delivered in 72.